000143323 001__ 143323
000143323 005__ 20240229112548.0
000143323 0247_ $$2doi$$a10.1159/000496407
000143323 0247_ $$2pmid$$apmid:30677754
000143323 0247_ $$2ISSN$$a0378-584X
000143323 0247_ $$2ISSN$$a1423-0240
000143323 0247_ $$2ISSN$$a2296-5262
000143323 0247_ $$2ISSN$$a2296-5270
000143323 037__ $$aDKFZ-2019-00913
000143323 041__ $$aeng
000143323 082__ $$a350
000143323 1001_ $$aVillalobos, Matthias$$b0
000143323 245__ $$aCommunication along Milestones in Lung Cancer Patients with Advanced Disease.
000143323 260__ $$aBasel$$bKarger$$c2019
000143323 3367_ $$2DRIVER$$aarticle
000143323 3367_ $$2DataCite$$aOutput Types/Journal article
000143323 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1554453559_6189$$xReview Article
000143323 3367_ $$2BibTeX$$aARTICLE
000143323 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143323 3367_ $$00$$2EndNote$$aJournal Article
000143323 520__ $$aPatients with advanced lung cancer and their caregivers are confronted with a complex situation as their disease-related burden comprises physical, psychosocial, and spiritual needs. During the illness trajectory with limited prognosis, they are exposed to different multidisciplinary healthcare settings and providers that challenge the continuity and coordination of care. Additionally, decision-making between active cancer treatment and end-of-life care constitutes a continuous balancing act. Several studies have shown that early integration of palliative care and adequate advance care planning improve quality of life and satisfaction with care. For this strategy, the communication skills of healthcare providers and interprofessional collaboration should be strengthened. A longitudinally structured communication approach along pivotal milestones of the disease can empower patients by facilitating coping and prognostic awareness, and achieve early integration of palliative care and advance care planning. Good interprofessional collaboration and communication lead to better coordination and continuity of care.
000143323 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000143323 588__ $$aDataset connected to CrossRef, PubMed,
000143323 7001_ $$0P:(DE-He78)9abc8949e87d718b8ae755bdc24c4a1e$$aSiegle, Anja$$b1$$udkfz
000143323 7001_ $$0P:(DE-He78)e8557b32dc6950a555b99b119cdd79de$$aHagelskamp, Laura$$b2$$udkfz
000143323 7001_ $$aJung, Corinna$$b3
000143323 7001_ $$aThomas, Michael$$b4
000143323 773__ $$0PERI:(DE-600)2749752-5$$a10.1159/000496407$$gVol. 42, no. 1-2, p. 41 - 46$$n1-2$$p41 - 46$$tOncology research and treatment$$v42$$x2296-5262$$y2019
000143323 909CO $$ooai:inrepo02.dkfz.de:143323$$pVDB
000143323 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9abc8949e87d718b8ae755bdc24c4a1e$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000143323 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e8557b32dc6950a555b99b119cdd79de$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000143323 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000143323 9141_ $$y2019
000143323 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz
000143323 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000143323 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143323 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143323 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143323 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bONCOL RES TREAT : 2017
000143323 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143323 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143323 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143323 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143323 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000143323 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143323 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000143323 9201_ $$0I:(DE-He78)G835-20160331$$kG835$$lAD Palliative Oncology$$x0
000143323 980__ $$ajournal
000143323 980__ $$aVDB
000143323 980__ $$aI:(DE-He78)G835-20160331
000143323 980__ $$aUNRESTRICTED